ERMA — Enorama Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00
- SEK148.62m
- SEK142.90m
- SEK1.36m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | — | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -22.9 | -23 | -26.9 | -41.5 | -42.1 |
Depreciation | |||||
Changes in Working Capital | -3.84 | -0.309 | -4.61 | 4.97 | -2.77 |
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -26.6 | -23 | -30.2 | -33 | -41.3 |
Capital Expenditures | -1.35 | -3.84 | -1.82 | 0 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -2.82 | — | — | — | 0 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | -4.17 | -3.84 | -1.82 | 0 | 0 |
Financing Cash Flow Items | 0 | — | -1.79 | -1.57 | 12 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 28.9 | 17 | 39.5 | 25.3 | 41.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.83 | -9.87 | 7.47 | -8.06 | 2.01 |